AI Solutions for Image-Guided Neuro-vascular Surgery

AI Solutions for Image-Guided Neuro-vascular Surgery

AI Solutions for Image-Guided Neuro-vascular Surgery

QAS.AI delivers real-time AI based decision support to assist neuroendovascular procedures—improving safety, precision, and outcomes for patients with complex cerebrovascular disease.

How It Works

From Angiography to Action in Under one Second

QAS.AI analyzes post-device angiograms in real time to forecast treatment success—predicting aneurysm occlusion at six months based on flow dynamics immediately after device placement.

In acute stroke, the system quantifies distal perfusion and provides automated mTICI scores following thrombectomy, with potential for deeper recanalization analytics.

Powered by thousands of annotated cases, QAS.AI delivers prognostic insight during the procedure—in under one second.

Key Benefits

Detect Aneurysms Instantly. Estimate Occlusion Likelihood with Confidence.

Detect Aneurysms Instantly. Estimate Occlusion Likelihood with Confidence.

Automated Aneurysm Detection

QAS.AI identifies aneurysms on any contrast-filled angiogram—pre- or post-device—highlighting them in real time with no manual input.

Standardized Data, Personalized Insight

Software auto-detects injection inlets and compensates for bias—ensuring clean, standardized data for reliable occlusion probability estimates, regardless of operator or equipment.

Software auto-detects injection inlets and compensates for bias—ensuring clean, standardized data for reliable occlusion probability estimates, regardless of operator or equipment.

Probability of successful treatment

68.52%

Outcome-Focused Guidance

Real-time insight empowers clinicians to adapt strategy during the procedure—supporting more confident decisions and stronger long-term outcomes.

Real-time insight empowers clinicians to adapt strategy during the procedure—supporting more confident decisions and stronger long-term outcomes.

Built for the Procedure Room

Adapt Instantly

With real-time occlusion probability, interventionalists can make informed decisions mid-procedure—adjusting device choice, repositioning, or strategy on the spot.

Seamless Workflow

QAS.AI integrates directly into angiographic imaging—providing feedback without disrupting flow, extending case time, or requiring additional steps.

Confidence in Diagnosis

With a 90%+ accuracy in lesion localization and inlet detection, QAS.AI reduces uncertainty and helps eliminate misdiagnoses due to imaging variability.

Scaling the Platform, Expanding the Impact

Expanded Indications

Our platform is evolving to support other flow-driven conditions including intracranial atherosclerosis, AVMs, and ischemic stroke.

Integrated Partnerships

Collaborations with imaging vendors and platform providers are enabling seamless integration across diverse clinical and surgical ecosystems

Ongoing Clinical Validation

Multi-center clinical studies are underway to validate QAS.AI as a predictive and diagnostic standard—accelerating regulatory pathways and clinical adoption.

Our Partners

Biomedical Engineering

Biomedical Engineering